PapersFlow Research Brief
Drug Solubulity and Delivery Systems
Research Guide
What is Drug Solubulity and Delivery Systems?
Drug Solubility and Delivery Systems is a field in pharmaceutical science that develops formulations such as cyclodextrins, solid dispersions, nanosuspensions, and lipid-based systems to enhance the solubility, absorption, and oral bioavailability of poorly soluble drugs.
This field encompasses 62,608 published works focused on improving drug solubility through techniques like amorphous pharmaceuticals and the Biopharmaceutics Classification System. Key methods include solid dispersions, nanosuspensions, and lipid-based formulations to boost gastrointestinal drug absorption. Research also covers polymeric materials and controlled release mechanisms from matrices and nanoparticles.
Topic Hierarchy
Research Sub-Topics
Cyclodextrins in Drug Solubilization
This sub-topic covers the use of cyclodextrin complexes to enhance solubility and stability of poorly water-soluble drugs. Researchers investigate inclusion complex formation, phase solubility studies, and formulation optimization.
Solid Dispersions for Amorphous Drug Delivery
This sub-topic examines polymeric solid dispersions to stabilize amorphous forms and improve dissolution rates. Researchers study polymer-drug interactions, recrystallization inhibition, and in vivo performance.
Nanosuspensions for Poorly Soluble Drugs
This sub-topic focuses on nanoparticle suspensions to increase saturation solubility via particle size reduction. Researchers explore milling techniques, stabilization surfactants, and pharmacokinetic enhancements.
Lipid-Based Formulations for Oral Delivery
This sub-topic investigates self-emulsifying lipid systems like SEDDS for lymphatic absorption and solubility. Researchers analyze lipid excipient selection, in vitro lipolysis, and bioavailability prediction.
Biopharmaceutics Classification System Applications
This sub-topic applies BCS to classify drugs and guide formulation strategies based on solubility-permeability. Researchers develop in silico models, IVIVC correlations, and regulatory biowaivers.
Why It Matters
Drug Solubility and Delivery Systems directly impacts oral drug bioavailability, a critical barrier for over 1100 drug candidates analyzed at GlaxoSmithKline, where reduced molecular flexibility improved absorption as shown by Veber et al. (2002) in "Molecular Properties That Influence the Oral Bioavailability of Drug Candidates". Lipinski et al. (2001) in "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1" established computational tools to predict solubility, enabling 17,478-cited advancements in drug discovery. Amidon et al. (1995) in "A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability" introduced the BCS, correlating in vitro dissolution with in vivo performance and classifying drugs into four categories to guide formulation strategies across the pharmaceutical industry.
Reading Guide
Where to Start
"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1" by Lipinski et al. (2001), as it provides foundational computational tools for solubility prediction with 17,478 citations, ideal for understanding core principles before advanced formulations.
Key Papers Explained
Lipinski et al. (2001) "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1" sets solubility estimation basics, which Veber et al. (2002) "Molecular Properties That Influence the Oral Bioavailability of Drug Candidates" builds on by linking properties like rotatable bonds to bioavailability in 1100 compounds. Amidon et al. (1995) "A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability" introduces BCS to classify drugs, informing Costa and Lobo (2001) "Modeling and comparison of dissolution profiles" for profile analysis. Higuchi (1963) "Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices" provides matrix release theory foundational to Ritger and Peppas (1987) kinetics.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current work extends biodegradable nanoparticles from Kumari et al. (2009) and Soppimath et al. (2001) to PEG alternatives per Knop et al. (2010), focusing on stealth properties without scalability limits. Emphasis remains on BCS-guided amorphous formulations and nanosuspensions for Class II/IV drugs, with dissolution modeling refinements.
Papers at a Glance
Frequently Asked Questions
What is the Biopharmaceutics Classification System?
The Biopharmaceutics Classification System categorizes drugs based on solubility and permeability to predict in vivo bioavailability from in vitro dissolution, as proposed by Amidon et al. (1995) in "A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability". This system divides drugs into four classes: high/low solubility and permeability combinations. It supports formulation development for oral delivery.
How do solid dispersions improve drug solubility?
Solid dispersions enhance drug solubility by dispersing poorly soluble drugs in hydrophilic carriers to create amorphous forms with higher dissolution rates. This approach is central to advances in gastrointestinal absorption. Techniques like those in Higuchi (1963) "Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices" model release from such matrices.
What role do polymeric nanoparticles play in delivery?
Biodegradable polymeric nanoparticles encapsulate drugs for controlled release, improving solubility and targeting, as reviewed by Kumari et al. (2009) in "Biodegradable polymeric nanoparticles based drug delivery systems" with 3590 citations. Soppimath et al. (2001) in "Biodegradable polymeric nanoparticles as drug delivery devices" details their design for sustained action. These systems protect drugs and enhance bioavailability.
How is drug release from matrices modeled?
Higuchi (1963) in "Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices" provides a mathematical model for release rates from solid matrices, cited 4711 times. Ritger and Peppas (1987) in "A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs" offer equations for Fickian and non-Fickian kinetics. These models predict dissolution profiles essential for formulation design.
What molecular properties affect oral bioavailability?
Veber et al. (2002) in "Molecular Properties That Influence the Oral Bioavailability of Drug Candidates" analyzed 1100 candidates and found reduced flexibility, measured by rotatable bonds, and polar surface area below 140 Ų key for rat oral bioavailability. Fewer than 10 rotatable bonds correlated with higher absorption. These properties guide candidate optimization.
What are common excipients in delivery systems?
The "Handbook of Pharmaceutical Excipients" by Rowe et al. (1994), cited 3508 times, references essential excipients for formulation stability and release. It covers materials used in tablets, capsules, and dispersions. Excipients enable solubility enhancement in solid dispersions and lipid formulations.
Open Research Questions
- ? How can computational models from Lipinski et al. (2001) be extended to predict solubility in novel lipid-based nanosuspensions?
- ? What dissolution profile models best integrate Fickian and non-Fickian release for amorphous solid dispersions under gastrointestinal conditions?
- ? Which biodegradable polymers optimize nanoparticle stability for oral delivery of BCS Class II drugs?
- ? How do PEGylation pros and cons, as in Knop et al. (2010), influence scalability of stealth delivery systems?
- ? Can BCS classifications predict bioavailability shifts from cyclodextrin complexation in solid dispersions?
Recent Trends
The field holds steady at 62,608 works with no specified 5-year growth, sustaining focus on cyclodextrins and solid dispersions.
Highly cited classics like Lipinski et al. with 17,478 citations and Veber et al. (2002) with 7705 citations continue dominating, indicating reliance on established solubility-permeability models.
2001No recent preprints or news signal shifts, reinforcing polymeric nanoparticles and BCS applications.
Research Drug Solubulity and Delivery Systems with AI
PapersFlow provides specialized AI tools for Pharmacology, Toxicology and Pharmaceutics researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Drug Solubulity and Delivery Systems with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Pharmacology, Toxicology and Pharmaceutics researchers